DTB select: Intranasal versus intramuscular naloxone for opioid overdose

Summary and context is provided on a clinical trial that found 0.8 mg naloxone given intranasally was not as effective as an intramuscular injection of 0.8 mg naloxone in reversing opioid overdose in people attending a supervised injecting facility.


Drug and Therapeutics Bulletin